Feed SYRS
SY

Syros Pharmaceuticals, Inc.

SYRS · OTC

$0.00 +0.00% (+$0.00)
1M +300.00%
Market Cap $9.39K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
0/9
Valuation
100 /100
Cheap
P/B 0.00x
P/S 0.00x
EV/FFO N/A
Growth
0 /100
Declining
Book val. growth 43.12%
Rev. growth 13.01%
FCF growth N/A
Profitability
20 /100
Weak
Op. margin 1,298.19%
Gross margin 77.33%
FCF margin 1,106.87%
Quality
1 /100
Poor
Asset turnover 0.06x
ROIC 91.82%
ROA 97.86%
Debt
50 /100
Moderate
Int. coverage -31.10x
Debt/Equity 3.73x
Net debt/EBITDA 0.49x
Stability
42 /100
Moderate
EPS volatility 13.07%
Beta 1.36x
Profitable years 0

Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več

Vprašajte StockBota o SYRS
Online

Sector

Healthcare

Industry

Biotechnology

CEO

James E. Bradner

Employees

68

Headquarters

Cambridge

Prihajajoči dogodki

29 OKT.

Earnings

Upcoming earnings report

37d

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe. Preberite naš Pravilnik o zasebnosti.